Establishing Quality Assurance for HIV-1 Rapid Test for Recent Infection in Thailand through the Utilization of Dried Tube Specimens
-
Published:2024-06-09
Issue:12
Volume:14
Page:1220
-
ISSN:2075-4418
-
Container-title:Diagnostics
-
language:en
-
Short-container-title:Diagnostics
Author:
Suparak Supaporn1ORCID, Unpol Petai1, Ngueanchanthong Kanokwan1ORCID, Chisholm Sirilada Pimpa1ORCID, Jomjunyoung Siriphailin1ORCID, Thanyacharern Wipawee1ORCID, Smanthong Nitis1ORCID, Pinrod Pojaporn1ORCID, Srithanaviboonchai Kriengkrai2, Yingyong Thitipong3, Tasaneeyapan Theerawit4ORCID, Nookhai Somboon4, Rojanawiwat Archawin1, Northbrook Sanny4ORCID
Affiliation:
1. Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand 2. Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand 3. Department of Disease Control, Ministry of Public Health, Nonthaburi 11000, Thailand 4. Division of Global HiV & Tuberculosis, U.S. Centers for Disease Control and Prevention, Nonthaburi 11000, Thailand
Abstract
The present study focuses on establishing the quality assurance of laboratories for recent infections (RTRI) in Thailand. We developed a cold-chain independent method, using fully characterized plasma obtained from the Thai Red Cross Society, and prepared as dried tube specimens (DTS). Twenty microliters of HIV-seronegative, recent, and long-term infected samples were aliquoted into individual tubes and dried at room temperature, 20–30 degrees Celsius, in a biosafety cabinet overnight to ensure optimal preservation. The DTS external quality control and external quality assessment were tested for homogeneity and stability following the ISO/Guide 35 guidelines. The DTS panels were distributed to 48 sites (FY 2022) and 27 sites (FY 2023) across 14 and 9 provinces, respectively, in Thailand. The results from participating laboratories were collected and evaluated for performance. The results were scored, and acceptable performance criteria were defined as the proportion of panels correctly tested, which was set at 100%. The satisfactory performance ranged from 96% to 100% and was not significantly different among the 13 health regions. The developed and implemented DTS panels can be used to monitor the quality of RTRI testing in Thailand.
Funder
President’s Emergency Plan for AIDS Relief
Reference21 articles.
1. Ministry of Public Health (2024, February 27). Strategic Plan for Ending the AIDS Epidemic in Thailand, 2023–2026; The National AIDS Management Center, Department of AIDS and Sexually Transmitted Infections Control, Ministry of Public Health. 2023. Volume 550, Available online: https://utoapp.moph.go.th/e_doc/views/uploads/64acc23133dc7-e416518ab6594503b7eef6bf9aa40bde-1470.pdf. 2. HIV Info HUB (2023, November 16). Estimated Number of HIV Infections, Available online: https://hivhub.ddc.moph.go.th/epidemic.php. 3. Yufenyuy, E.L., Detorio, M., Dobbs, T., Patel, H.K., Jackson, K., Vedapuri, S., and Parekh, B.S. (2022). Performance evaluation of the Asante Rapid Recency Assay for verification of HIV diagnosis and detection of recent HIV-1 infections: Implications for epidemic control. PLoS Glob. Public Health, 2. 4. Agyemang, E.A., Kim, A.A., Dobbs, T., Zungu, I., Payne, D., Maher, A.D., Curran, K., Kim, E., Kwalira, H., and Limula, H. (2022). Performance of a novel rapid test for recent HIV infection among newly-diagnosed pregnant adolescent girls and young women in four high-HIV-prevalence districts—Malawi, 2017–2018. PLoS ONE, 17. 5. (2019). Asanté™ HIV-1 Rapid Recency® Assay, Sedia Biosciences Corparation. [Package Insert].
|
|